GNOM Stock Global X Genomics & Biotechnology ETF (GNOM, $10) Stochastic Oscillator left the overbought zone on January 29, 2025

GET DAILY SIGNALS

Get AI intraday signals

GNOM - Global X Genomics & Biotechnology ETF

Stochastic signal

View

Odds of DOWN Trend

Price: $10

Daily change: -$0.13 (-1.32%)

Daily volume: 27K

Net Assets: $70.6M

GNOM saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for GNOM moved out of overbought territory on January 29, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 71 similar instances where the indicator exited the overbought zone. In of the 71 cases the stock moved lower. This puts the odds of a downward move at .

Technical Analysis (Indicators)

Bearish Trend Analysis

GNOM moved below its 50-day moving average on January 27, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNOM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GNOM broke above its upper Bollinger Band on January 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for GNOM entered a downward trend on January 22, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 27, 2025. You may want to consider a long position or call options on GNOM as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GNOM just turned positive on January 21, 2025. Looking at past instances where GNOM's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GNOM advanced for three days, in of 285 cases, the price rose further within the following month. The odds of a continued upward trend are .